Back to search
FDAFDA · Food and drugs·Recall number D-441-2013

Lloyd Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.

Published May 29, 2013 · Recall initiated: April 1, 2013

Summary

FDA records drug Class II recall D-441-2013, published May 29, 2013 and initiated April 1, 2013. Recalling firm: Lloyd Inc. of Iowa; Status: Terminated; Reported quantity: 3,844,402 tablets; Lot: Lot #: HD31411, Exp May-13; HC04112, Exp Aug-13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lloyd Inc. of Iowa
Distributor
The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.
Lot
Lot #: HD31411, Exp May-13; HC04112, Exp Aug-13.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lloyd Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA. recalled?

Yes. FDA published recall D-441-2013 on May 29, 2013. Reported hazard: cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.

What should I do if I have this product?

Voluntary: Firm initiated · Letter